ArticleCancers2026

Survival Outcomes Following Yttrium-90 and Holmium-166 Transarterial Radioembolization for Hepatocellular Carcinoma.

Dávid Ádám Korda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.